keyword
https://read.qxmd.com/read/38682450/changes-in-psychiatric-medication-use-during-the-covid-19-pandemic-in-a-pediatric-long-term-care-facility
#1
JOURNAL ARTICLE
Corrie Harris, Mst Sharmin Akter Sumy, Yana B Feygin, Heather Huxol, Ademilola Tejuoso, Theresa Kluthe, Scott Bickel
Background: Coronavirus disease 2019 (COVID-19) caused a global pandemic that dramatically altered infection control procedures in long-term care facilities. Mental health decline among residents of geriatric facilities during the pandemic has been described (Ferro Uriguen et al., 2022). Our study aims to evaluate psychological effects of the pandemic on residents of a pediatric long-term care facility, a population comprised of medically complex children. To characterize this, we compared patterns of psychotropic medication use during the COVID-19 pandemic to those of the prepandemic period among residents of a 76-bed pediatric long-term care facility...
April 29, 2024: Journal of Child and Adolescent Psychopharmacology
https://read.qxmd.com/read/38680970/pathways-for-diagnosing-and-treating-ckd-associated-pruritus-a-narrative-review
#2
REVIEW
Claudio Rigatto, David Collister, Alexandre Granger-Vallée, Louis Girard, Jay Hingwala, Angelo Karaboyas, Adeera Levin, Philip McFarlane, Ron Pisoni, Bhanu Prasad, Normand Proulx, Daniel Schwartz, Manish Sood, Rita Suri, Karthik Tennankore
PURPOSE OF REVIEW: Chronic kidney disease (CKD)-associated pruritus is a common, persistent, and distressing itch experienced by patients across the CKD spectrum. Although the disorder is associated with adverse outcomes and poor health-related quality of life, it remains underdiagnosed and undertreated. The purpose of this narrative review is to offer health care providers guidance on how to effectively identify, assess, and treat patients with CKD-associated pruritus, with the goal of reducing symptom burden and improving patient-important outcomes, such as quality of life (QoL)...
2024: Canadian Journal of Kidney Health and Disease
https://read.qxmd.com/read/38677507/asociaci%C3%A3-n-espa%C3%A3-ola-de-neurogastroenterologia-y-motilidad-asenem-updated-review-on-the-management-of-functional-abdominal-pain
#3
REVIEW
Jordi Serra, Ariadna Aguilar, Elizabeth Barba, Constanza Ciriza de Los Ríos, Laura Garcia Pravia, Vicente Martínez, Blanca Serrano Falcón
Functional abdominal pain is a disorder in which central and peripheral sensitization processes converge, leading to hypersensitivity and allodynia. Differential diagnosis is made with organic digestive, renal, gynecological, endocrine, or neurological diseases. Treatment should be individualized for each patient. In cases of debilitating pain, therapy combining drugs with different mechanisms of action can be initiated, while in less severe cases, therapy with a progressive introduction of drugs based on clinical response is advised...
April 25, 2024: Gastroenterología y Hepatología
https://read.qxmd.com/read/38676664/patterns-of-gabapentin-prescription-and-of-hospitalization-in-a-national-cohort-of-us-veterans
#4
JOURNAL ARTICLE
Deborah R Levy, Kirsha S Gordon, Lori A Bastian, Cynthia Brandt, Craig Gunderson
No abstract text is available yet for this article.
April 27, 2024: Pain Medicine
https://read.qxmd.com/read/38675500/advancing-postoperative-pain-management-in-oral-cancer-patients-a-systematic-review
#5
REVIEW
Angelo Michele Inchingolo, Gianna Dipalma, Alessio Danilo Inchingolo, Irene Palumbo, Mariafrancesca Guglielmo, Roberta Morolla, Antonio Mancini, Francesco Inchingolo
The goal of this review is to shed light on the management of orofacial discomfort after a cancer diagnosis in the head and neck region. A search was conducted on PubMed, Scopus, and Web of Science to identify studies on postoperative pain control in oral cancer. The review included open-access research, investigations into pain management, randomized clinical trials, retrospective studies, case-control studies, prospective studies, English-written studies, and full-text publications. Exclusion criteria included animal studies; in vitro studies; off-topic studies; reviews, case reports, letters, or comments; and non-English language...
April 22, 2024: Pharmaceuticals
https://read.qxmd.com/read/38669783/implementing-change-sustaining-enhanced-recovery-after-surgery-protocols-in-pediatric-surgery-using-iterative-assessments
#6
JOURNAL ARTICLE
Allison R Thompson, Jack P Vernamonti, Paris Rollins, K Elizabeth Speck
INTRODUCTION: While Enhanced Recovery After Surgery (ERAS) protocols are becoming more common in pediatric surgery, there is still little published about protocol compliance and sustainability. METHODS: This is a prospective observational study to evaluate the compliance of an ERAS protocol for pectus repair at a large academic children's hospital. Our primary outcome was overall protocol compliance at 1-y postimplementation of the ERAS protocol. Our comparison group included all pectus repairs for 2 y before protocol implementation...
April 25, 2024: Journal of Surgical Research
https://read.qxmd.com/read/38663398/%C3%AE-2%C3%AE-1-mediated-maladaptive-sensory-plasticity-disrupts-adipose-tissue-homeostasis-following-spinal-cord-injury
#7
JOURNAL ARTICLE
Debasish Roy, Elliot Dion, Jesse A Sepeda, Juan Peng, Sai Rishik Lingam, Kristy Townsend, Andrew Sas, Wenjing Sun, Andrea Tedeschi
Spinal cord injury (SCI) increases the risk of cardiometabolic disorders, including hypertension, dyslipidemia, and insulin resistance. Not only does SCI lead to pathological expansion of adipose tissue, but it also leads to ectopic lipid accumulation in organs integral to glucose and insulin metabolism. The pathophysiological changes that underlie adipose tissue dysfunction after SCI are unknown. Here, we find that SCI exacerbates lipolysis in epididymal white adipose tissue (eWAT). Whereas expression of the α2δ1 subunit of voltage-gated calcium channels increases in calcitonin gene-related peptide-positive dorsal root ganglia neurons that project to eWAT, conditional deletion of the gene encoding α2δ1 in these neurons normalizes eWAT lipolysis after SCI...
April 15, 2024: Cell reports medicine
https://read.qxmd.com/read/38662459/risk-of-adverse-outcomes-during-gabapentinoid-therapy-and-factors-associated-with-increased-risk-in-uk-primary-care-using-the-clinical-practice-research-datalink-a-cohort-study
#8
JOURNAL ARTICLE
Sara Muller, James Bailey, Ram Bajpai, Toby Helliwell, Sarah A Harrisson, Rebecca Whittle, Christian D Mallen, Julie Ashworth
Growing evidence from pharmacovigilance data and postmortem toxicology reports highlights the misuse potential of gabapentinoids. This study aimed to investigate the risk of serious adverse outcomes (drug misuse, overdose, major trauma), and their risk factors, in primary care patients who are prescribed gabapentinoids. Using the UK Clinical Practice Research Datalink, a matched cohort study calculated adverse event rates separately for gabapentinoid-exposed and unexposed cohorts. In the exposed cohort, event rates for exposure to a range of potential risk factors were calculated...
April 11, 2024: Pain
https://read.qxmd.com/read/38651606/efficacy-and-safety-of-gabapentinoids-for-acute-herpes-zoster-neuralgia-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials
#9
JOURNAL ARTICLE
Yinluo Li, Xingzhen Long, Fengrong Luo, Jiarui Zhang, Shaoqin Sun, Pengqiang Du, Hongtao Yang, Qi Chen, Changcheng Sheng, Xue Bai
OBJECTIVE: his study aimed to systematically evaluate the clinical efficacy of gabapentin and pregabalin in the treatment of acute herpes zoster neuralgia, including pain control and the occurrence of adverse effects. METHOD: A systematic computerized search was conducted in October 2023 in PubMed, Embase, Web of Science, Cochrane Library, VIP, CNKI, and Wanfang databases. Data from randomized controlled trials comparing gabapentin analogs for the treatment of acute herpes zoster neuralgia were searched...
April 23, 2024: Clinical Journal of Pain
https://read.qxmd.com/read/38646551/efficacy-and-safety-of-different-systemic-drugs-in-the-treatment-of-uremic-pruritus-among-hemodialysis-patients-a-network-meta-analysis-based-on-randomized-clinical-trials
#10
Xueqian Zhao, Haipeng Sun, Wei Li
AIM: This network meta-analysis was to analyze and rank the efficacy and safety of different systemic drugs in the treatment of uremic pruritus (UP) among hemodialysis patients. METHOD: PubMed, Embase, Cochrane Library, and Web of Science databases were searched from inception to 10 July 2023 for randomized controlled trials (RCTs) investigating different drugs in the treatment of UP among hemodialysis patients. Drugs including cromolyn sodium, dexchlorpheniramine, difelikefalin, gabapentin, hydroxyzine, ketotifen, melatonin, montelukast, nalbuphine, nalfurafine, nemolizumab, nicotinamide, pregabalin, sertraline, thalidomide, and placebo were assessed...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38641202/neuropathic-pain-evidence-based-recommendations
#11
JOURNAL ARTICLE
Xavier Moisset
Neuropathic pain continues to be a significant problem that lacks effective solutions for every single patient. In 2015, international guidelines (NeuPSIG) were published, while the French recommendations were updated in 2020. The purpose of this minireview is to provide an update on the process of developing evidence-based recommendations and explore potential changes to the current recommendations. Primary treatments for neuropathic pain include selective serotonin-norepinephrine reuptake inhibitors (SNRIs) such as duloxetine and venlafaxine, gabapentin, tricyclic antidepressants, as well as topical lidocaine and transcutaneous electrical nerve stimulation, which are specifically suggested for focal peripheral neuropathic pain...
April 17, 2024: La Presse Médicale
https://read.qxmd.com/read/38636787/pharmacotherapy-and-noninvasive-neurostimulation-for-neuropathic-pain
#12
JOURNAL ARTICLE
Annachiara Spagna, Nadine Attal
Neuropathic pain poses a significant challenge due to its complex mechanisms, necessitating specific treatments. In recent decades, significant progress has been made in the clinical research of neuropathic pain, marking a shift from empirical strategies to evidence-based medicine in its management. This review outlines both pharmacological and non-pharmacological interventions. Antidepressants (tricyclic and serotonin-noradrenaline reuptake inhibitors), antiepileptics (gabapentin, pregabalin), and topical agents constitute the main pharmacological treatments...
April 16, 2024: La Presse Médicale
https://read.qxmd.com/read/38636564/spinal-neuronal-activity-and-neuroinflammatory-component-in-a-mouse-model-of-cfa-induced-vestibulodynia
#13
JOURNAL ARTICLE
Serena Boccella, Michela Perrone, Antimo Fusco, Roozbe Bonsale, Rosmara Infantino, Silvia Nuzzo, Giovanni Pecoraro, Federica Ricciardi, Andrea Maria Morace, Gianluca Petrillo, Ilaria Leone, Monica Franzese, Vito de Novellis, Francesca Guida, Marco Salvatore, Sabatino Maione, Livio Luongo
Vestibulodynia is a complex pain disorder characterized by chronic discomfort in the vulvar region, often accompanied by tactile allodynia and spontaneous pain. In patients a depressive behaviour is also observed. In this study, we have used a model of vestibulodynia induced by complete Freund's adjuvant (CFA) focusing our investigation on the spinal cord neurons and microglia. We investigated tactile allodynia, spontaneous pain, and depressive-like behavior as key behavioral markers of vestibulodynia. In addition, we conducted in vivo electrophysiological recordings to provide, for the first time to our knowledge, the characterization of the spinal sacral neuronal activity in the L6-S1 dorsal horn of the spinal cord...
April 16, 2024: Brain, Behavior, and Immunity
https://read.qxmd.com/read/38631907/general-practitioners-risk-literacy-and-real-world-prescribing-of-potentially-hazardous-drugs-a-cross-sectional-study
#14
JOURNAL ARTICLE
Odette Wegwarth, Tammy C Hoffmann, Ben Goldacre, Claudia Spies, Helge A Giese
BACKGROUND: Overuse of medical care is a pervasive problem. Studies using hypothetical scenarios suggest that physicians' risk literacy influences medical decisions; real-world correlations, however, are lacking. We sought to determine the association between physicians' risk literacy and their real-world prescriptions of potentially hazardous drugs, accounting for conflicts of interest and perceptions of benefit-harm ratios in low-value prescribing scenarios. SETTING AND SAMPLE: Cross-sectional study-conducted online between June and October 2023 via field panels of Sermo (Hamburg, Germany)-with a convenience sample of 304 English general practitioners (GPs)...
April 17, 2024: BMJ Quality & Safety
https://read.qxmd.com/read/38630850/nociceptor-spontaneous-activity-is-responsible-for-fragmenting-non-rapid-eye-movement-sleep-in-mouse-models-of-neuropathic-pain
#15
JOURNAL ARTICLE
Chloe Alexandre, Giulia Miracca, Victor Duarte Holanda, Ashley Sharma, Kamila Kourbanova, Ashley Ferreira, Maíra A Bicca, Xiangsunze Zeng, Victoria A Nassar, Seungkyu Lee, Satvinder Kaur, Sridevi V Sarma, Pierre Sacré, Thomas E Scammell, Clifford J Woolf, Alban Latremoliere
Spontaneous pain, a major complaint of patients with neuropathic pain, has eluded study because there is no reliable marker in either preclinical models or clinical studies. Here, we performed a comprehensive electroencephalogram/electromyogram analysis of sleep in several mouse models of chronic pain: neuropathic (spared nerve injury and chronic constriction injury), inflammatory (Freund's complete adjuvant and carrageenan, plantar incision) and chemical pain (capsaicin). We find that peripheral axonal injury drives fragmentation of sleep by increasing brief arousals from non-rapid eye movement sleep (NREMS) without changing total sleep amount...
April 17, 2024: Science Translational Medicine
https://read.qxmd.com/read/38630836/calcineurin-regulates-synaptic-ca-2-permeable-ampa-receptors-in-hypothalamic-presympathetic-neurons-via-%C3%AE-2%C3%AE-1-mediated-glua1-glua2-assembly
#16
JOURNAL ARTICLE
Jing-Jing Zhou, Jian-Ying Shao, Shao-Rui Chen, Hong Chen, Hui-Lin Pan
Hypertension is a major adverse effect of calcineurin inhibitors, such as tacrolimus (FK506) and cyclosporine, used clinically as immunosuppressants. Calcineurin inhibitor-induced hypertension (CIH) is linked to augmented sympathetic output from the hypothalamic paraventricular nucleus (PVN). GluA2-lacking, Ca2+ -permeable AMPA receptors (CP-AMPARs) are a key feature of glutamatergic synaptic plasticity, yet their role in CIH remains elusive. Here, we found that systemic administration of FK506 in rats significantly increased serine phosphorylation of GluA1 and GluA2 in PVN synaptosomes...
April 17, 2024: Journal of Physiology
https://read.qxmd.com/read/38623445/impact-of-gabapentin-on-postoperative-hypotension-in-enhanced-recovery-after-surgery-protocols-for-microvascular-breast-reconstruction
#17
JOURNAL ARTICLE
Corbin E Muetterties, Jeremiah M Taylor, Diana E Kaeding, Ricardo Rosales Morales, Anissa V Nguyen, Lorna Kwan, Charles Y Tseng, Michael R Delong, Jaco H Festekjian
BACKGROUND: Enhanced recovery after surgery (ERAS) protocols have been associated with hypotensive episodes after autologous breast reconstruction. Gabapentin (Gaba), a nonopioid analgesic used in ERAS, has been shown to attenuate postoperative hemodynamic responses. This study assesses ERAS's impact, with and without Gaba, on postoperative hypotension after microvascular breast reconstruction. METHODS: Three cohorts were studied: traditional pathway, ERAS + Gaba, and ERAS no-Gaba...
April 2024: Plastic and Reconstructive Surgery. Global Open
https://read.qxmd.com/read/38623317/managing-opioid-withdrawal-symptoms-during-the-fentanyl-crisis-a-review
#18
REVIEW
Andrea Nicole Weber, Joshua Trebach, Marielle A Brenner, Mary Margaret Thomas, Nicholas L Bormann
Illicitly manufactured fentanyl (IMF) is a significant contributor to the increasing rates of overdose-related deaths. Its high potency and lipophilicity can complicate opioid withdrawal syndromes (OWS) and the subsequent management of opioid use disorder (OUD). This scoping review aimed to collate the current OWS management of study populations seeking treatment for OWS and/or OUD directly from an unregulated opioid supply, such as IMF. Therefore, the focus was on therapeutic interventions published between January 2010 and November 2023, overlapping with the period of increasing IMF exposure...
2024: Substance Abuse and Rehabilitation
https://read.qxmd.com/read/38611760/monitoring-pharmaceuticals-and-personal-care-products-in-healthcare-effluent-wastewater-samples-and-the-effectiveness-of-drug-removal-in-wastewater-treatment-plants-using-the-uhplc-ms-ms-method
#19
JOURNAL ARTICLE
Lucia Molnarova, Tatana Halesova, Daniela Tomesova, Marta Vaclavikova, Zuzana Bosakova
A multi-residue UHPLC-MS/MS analytical method, previously developed for monitoring 52 pharmaceuticals in drinking water, was used to analyse these pharmaceuticals in wastewater originating from healthcare facilities in the Czech Republic. Furthermore, the methodology was expanded to include the evaluation of the effectiveness of drug removal in Czech wastewater treatment plants (WWTPs). Of the 18 wastewater samples analysed by the validated UHPLC-MS/MS, each sample contained at least one quantifiable analyte...
March 27, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38606931/reductions-in-world-health-organization-risk-drinking-level-are-associated-with-improvements-in-sleep-problems-among-individuals-with-alcohol-use-disorder
#20
JOURNAL ARTICLE
Christian C Garcia, Dylan K Richards, Felicia R Tuchman, Kevin A Hallgren, Henry R Kranzler, Henri-Jean Aubin, Stephanie S O'Malley, Karl Mann, Arnie Aldridge, Michaela Hoffman, Raymond F Anton, Katie Witkiewitz
AIMS: Among individuals with alcohol use disorder (AUD), sleep disturbances are pervasive and contribute to the etiology and maintenance of AUD. However, despite increased attention toward the relationship between alcohol use and sleep, limited empirical research has systematically examined whether reductions in drinking during treatment for AUD are associated with improvements in sleep problems. METHODS: We used data from a multisite, randomized, controlled trial that compared 6 months of treatment with gabapentin enacarbil extended-release with placebo for adults with moderate-to-severe AUD (N = 346)...
March 16, 2024: Alcohol and Alcoholism
keyword
keyword
2551
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.